Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.18)
# 4,095
Out of 4,829 analysts
313
Total ratings
4.05%
Success rate
-57.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FEMY Femasys | Maintains: Buy | $15 → $12 | $1.08 | +1,011.11% | 22 | May 9, 2025 | |
| AGEN Agenus | Reiterates: Neutral | n/a | $3.50 | - | 16 | Apr 30, 2025 | |
| OLMA Olema Pharmaceuticals | Reiterates: Buy | $30 | $4.75 | +532.24% | 20 | Apr 28, 2025 | |
| SANA Sana Biotechnology | Reiterates: Buy | $11 | $2.00 | +450.00% | 11 | Apr 24, 2025 | |
| BCTX BriaCell Therapeutics | Reiterates: Buy | $32 | $3.13 | +922.36% | 14 | Apr 22, 2025 | |
| RNAZ TransCode Therapeutics | Maintains: Buy | $20 → $10 | $0.36 | +2,699.55% | 17 | Apr 16, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $36 | $21.34 | +68.67% | 1 | Apr 9, 2025 | |
| CNTB Connect Biopharma Holdings | Reiterates: Buy | $8 | $0.78 | +925.64% | 6 | Apr 1, 2025 | |
| IOBT IO Biotech | Reiterates: Buy | $12 | $0.99 | +1,110.90% | 13 | Apr 1, 2025 | |
| GNLX Genelux | Reiterates: Buy | $30 | $2.78 | +979.14% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.20 | +1,483.33% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $2.02 | +791.09% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.81 | +1,628.40% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.83 | +742.26% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.79 | +536.94% | 11 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $7.60 | +360.53% | 12 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.43 | +590.77% | 8 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.28 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $4.73 | +745.67% | 9 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $22 | $20.03 | +9.84% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $8.80 | +172.73% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $29.14 | +99.04% | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.41 | +4,278.50% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.23 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $18.59 | +104.41% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $6 | $2.49 | +141.45% | 13 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $59.46 | +93.42% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $2.25 | +1,366.67% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.15 | - | 1 | Apr 25, 2024 |
Femasys
May 9, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $1.08
Upside: +1,011.11%
Agenus
Apr 30, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.50
Upside: -
Olema Pharmaceuticals
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $4.75
Upside: +532.24%
Sana Biotechnology
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $2.00
Upside: +450.00%
BriaCell Therapeutics
Apr 22, 2025
Reiterates: Buy
Price Target: $32
Current: $3.13
Upside: +922.36%
TransCode Therapeutics
Apr 16, 2025
Maintains: Buy
Price Target: $20 → $10
Current: $0.36
Upside: +2,699.55%
vTv Therapeutics
Apr 9, 2025
Initiates: Buy
Price Target: $36
Current: $21.34
Upside: +68.67%
Connect Biopharma Holdings
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $0.78
Upside: +925.64%
IO Biotech
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $0.99
Upside: +1,110.90%
Genelux
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $2.78
Upside: +979.14%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.20
Upside: +1,483.33%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $2.02
Upside: +791.09%
Mar 26, 2025
Reiterates: Buy
Price Target: $14
Current: $0.81
Upside: +1,628.40%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.83
Upside: +742.26%
Mar 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.79
Upside: +536.94%
Mar 18, 2025
Reiterates: Buy
Price Target: $35
Current: $7.60
Upside: +360.53%
Mar 17, 2025
Reiterates: Buy
Price Target: $3
Current: $0.43
Upside: +590.77%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.28
Upside: -
Mar 11, 2025
Reiterates: Buy
Price Target: $40
Current: $4.73
Upside: +745.67%
Mar 4, 2025
Reiterates: Neutral
Price Target: $22
Current: $20.03
Upside: +9.84%
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $8.80
Upside: +172.73%
Feb 24, 2025
Reiterates: Buy
Price Target: $58
Current: $29.14
Upside: +99.04%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.41
Upside: +4,278.50%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.23
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $18.59
Upside: +104.41%
Jan 7, 2025
Maintains: Neutral
Price Target: $8 → $6
Current: $2.49
Upside: +141.45%
Dec 10, 2024
Reiterates: Buy
Price Target: $115
Current: $59.46
Upside: +93.42%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $2.25
Upside: +1,366.67%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.15
Upside: -